Stock listing

TPEx:6696 Lin BioScience, Inc. (仁新*) 股價

Follow Lin BioScience, Inc. into a list and get an email when it puts out news.

Share price · TPEX:6696

$119.50 TWD -33.00 (-21.6%)

Close on Nov 20, 2026

Past year +348.4% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$110.00 – $156.00 TWDNov 20, 2026
Volume
17.20M sharesNov 20, 2026
Market cap
$99.09B TWDAt the close on Nov 20, 2026 · price × 829.2M shares outstanding
52-week range
$24.75 – $207.00 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1.26B TWDMedian day 5.36M shares · 8 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Lin BioScience, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6696 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$119.50-33.00-21.6%$155.00$156.00$110.0017,197,427
$152.50-9.50-5.9%$166.50$166.50$148.506,406,617
$162.00-2.50-1.5%$166.50$168.00$159.502,375,663
$164.50+0.50+0.3%$166.00$168.00$159.002,911,693
$164.00-14.50-8.1%$177.00$179.00$163.007,117,107
$178.50+8.50+5.0%$175.00$187.00$172.509,126,282
$170.00+4.50+2.7%$164.50$173.50$161.506,198,390
$165.50+3.00+1.8%$163.50$168.50$159.003,473,481
$162.50+4.50+2.8%$161.00$175.50$159.004,079,937
$158.00+11.50+7.8%$150.00$160.50$150.003,593,137
$146.50-5.00-3.3%$150.00$156.00$128.008,904,010
$151.50-7.00-4.4%$162.00$162.50$150.504,654,735
$158.50-2.00-1.2%$162.00$164.50$157.503,188,347
$160.50-9.50-5.6%$168.00$173.00$158.505,363,870
$170.00+10.50+6.6%$159.00$172.00$157.504,311,889
$159.50-2.50-1.5%$161.50$163.00$153.003,626,564
$162.00+2.50+1.6%$161.00$166.50$159.503,500,310
$159.50+2.00+1.3%$159.00$161.50$156.002,750,158
$157.50-4.00-2.5%$162.50$163.50$155.504,077,819
$161.500.000.0%$161.50$161.50$161.500
$161.50-9.50-5.6%$171.00$172.00$161.503,823,025
$171.00+7.00+4.3%$167.00$177.00$164.004,385,476
$164.00+7.00+4.5%$160.00$169.50$156.004,321,110
$157.00-9.00-5.4%$163.50$166.00$149.009,845,753
$166.00+3.00+1.8%$164.50$172.00$160.004,258,603
$163.00-2.50-1.5%$164.50$172.50$155.0010,131,309
$165.50-5.00-2.9%$172.00$172.00$163.506,878,700
$170.50-1.00-0.6%$172.00$180.00$168.004,720,343
$171.50-4.50-2.6%$173.00$185.00$170.003,654,119
$176.00+3.00+1.7%$175.00$179.50$172.502,695,780
$173.00-4.00-2.3%$179.00$180.00$170.504,649,657
$177.00+5.00+2.9%$170.50$181.00$169.004,693,965
$172.00-10.00-5.5%$180.00$184.00$170.5011,165,610
$182.00-4.00-2.2%$185.00$191.00$178.009,111,353
$186.00-4.50-2.4%$191.00$195.50$186.005,644,419
$190.50+4.50+2.4%$189.00$194.00$186.504,387,870
$186.00-11.50-5.8%$197.00$202.00$182.509,194,139
$197.50+3.50+1.8%$190.00$201.00$181.007,770,671
$194.00-1.00-0.5%$197.50$207.00$190.0014,418,930
$195.00+28.00+16.8%$168.00$197.00$168.0017,611,754
$167.00+2.00+1.2%$165.50$170.00$164.503,654,781
$165.00-2.50-1.5%$168.50$170.50$160.005,614,560
$167.50+4.50+2.8%$160.00$170.50$160.006,044,991
$163.00-5.00-3.0%$170.00$171.50$160.009,644,479
$168.00+1.00+0.6%$167.00$177.00$166.0010,525,183
$167.00+4.00+2.5%$163.50$170.00$155.008,317,730
$163.00-5.00-3.0%$167.50$169.00$150.0014,946,462
$168.00-0.50-0.3%$168.00$175.00$158.0011,461,152
$168.50-11.00-6.1%$179.00$180.00$166.0012,412,616
$179.50+5.00+2.9%$177.00$196.00$159.0024,866,858
$174.50+29.00+19.9%$146.00$200.00$134.0040,922,578
$145.50+27.50+23.3%$120.00$145.50$112.5029,987,508
$118.00+21.40+22.2%$97.00$120.50$95.0026,567,036
$96.60+9.30+10.7%$85.40$98.90$82.2014,925,560
$87.30-8.40-8.8%$96.90$99.00$86.7017,533,685
$95.70+2.00+2.1%$96.00$109.00$89.7022,928,381
$93.700.000.0%$93.70$93.70$93.700
$93.700.000.0%$93.70$93.70$93.700
$93.700.000.0%$93.70$93.70$93.700
$93.700.000.0%$93.70$93.70$93.700
$93.700.000.0%$93.70$93.70$93.700
$93.700.000.0%$93.70$93.70$93.700
$93.700.000.0%$93.70$93.70$93.700

Splits

1 split · TPEX:6696 · every price before a split is adjusted for it

DayRatioWhat
10-for-1Split
Ticker
TPEx:6696
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TPEx
Currency
TWD

What changed lately

Latest news

All Lin BioScience, Inc. news

Lin BioScience, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
1 in all · newest Nov 27, 2024 · oldest 2024
Decks
10 decks · latest July 2026

Valuation

Price/book 9.3× against a median of 3.6×: 9th lowest of 11 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$82.49B TWD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
9.3×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Lin BioScience, Inc. · TPEX:6696US$3.01BUS$2.50Bn/an/an/a9.3×n/a0.0×n/a
Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLXUS$3.35BUS$2.58Bn/an/an/a4.4×n/a0.0×1.21
Iovance Biotherapeutics, Inc. · NASDAQ:IOVAUS$3.19BUS$2.86Bn/a7.5×n/a3.9×−58.2%0.1×1.62
AbCellera Biologics Inc. · NASDAQ:ABCLUS$3.16BUS$2.53Bn/a37.3×n/a3.0×−218.5%0.1×2.42
Viking Therapeutics, Inc. · NASDAQ:VKTXUS$3.16BUS$2.20Bn/an/an/a5.4×n/a0.0×1.31
Legend Biotech Corp. · NASDAQ:LEGNUS$2.97BUS$2.28Bn/a1.7×27.0×2.3×−0.0%0.1×0.75
Denali Therapeutics Inc. · NASDAQ:DNLIUS$2.96BUS$2.69Bn/a126×n/a3.2×n/a0.3×1.30
Dyne Therapeutics, Inc. · NASDAQ:DYNUS$2.90BUS$1.97Bn/an/an/a3.1×n/a0.2×1.51
Shanghai Junshi Biosciences Co., Ltd. Class A · SSE:688180US$2.88BUS$2.99Bn/a8.0×n/a3.2×−35.0%0.7×n/a
SELLAS Life Sciences Group, Inc. · NASDAQ:SLSUS$2.78BUS$2.65Bn/an/an/a21.1×n/a0.0×2.19
HLB Co., Ltd. · KRX:028300US$2.69BUS$2.69Bn/a36.9×n/a10.4×−219.1%0.2×n/a
Median of the othersUS$2.96BUS$2.62B22.4×27.0×3.6×−58.2%0.1×1.41

Team and board

Officers

OfficerRole
Serena ChenCFO
Irene WangPresident & CSO

Board

DirectorRole
Tom LinChairman

Decks

DeckKindSlidesDate
Investor Presentation (July 2026)Investor deck44 slidesJuly 2026
Investor Presentation (February 2026)Investor deck44 slidesFebruary 2026
Investor Presentation (September 2025)Investor deck37 slidesSeptember 2025
Investor Presentation (July 2025)Investor deck37 slidesJuly 2025
Investor Presentation (January 2025)Investor deck35 slidesJanuary 2025
Investor Presentation (December 2023)Investor deck33 slidesDecember 2023
Investor Presentation (December 2023)Investor deck31 slidesDecember 2023
Investor Presentation (November 2023)Investor deck30 slidesNovember 2023
Investor Presentation (September 2022)Investor deck30 slidesSeptember 2022
Investor Presentation (2022)Investor deck23 slidesApr 14, 2022

Open Decks

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cost of revenue20.2M17.9M11.2M4.39M4.08M4.31M
Gross profit-20.2M-17.9M-11.2M-4.39M-4.08M-4.31M
Research and development1.61B1.10B854.1M320.9M244.8M145.0M193.3M
Selling, general and administrative1.24B355.9M240.5M120.0M89.6M49.1M
Operating income-2.86B-1.46B-1.10B-445.1M-338.3M-197.0M-238.2M
Depreciation and amortization23.8M20.2M17.9M11.2M4.39M4.08M4.31M
EBITDA-2.83B-1.44B-1.08B-434.0M-333.9M-192.9M-233.9M
Interest expense1.02M1.00M1.21M875.0K71.0K261.0K
Income before tax-2.64B-1.33B-1.09B-477.9M-490.4M-174.8M-240.0M
Income tax69.6M-29.7M-18.4M-9.51M-23.0M-4.78M
Net income-1.36B-744.3M-687.2M-313.5M-434.7M-151.8M-235.3M
Earnings per share, basic-1.65-9.47-9.23-4.37-6.23-2.39-3.87

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents11.9B1.49B3.26B1.65B806.8M1.09B117.1M
Short-term investments4.38B3.72B
Receivables18.9M25.5M110.0K1.49M27.0K96.0K
Current assets16.5B5.35B3.42B1.67B819.5M1.11B129.6M
Total assets25.4B5.53B3.60B1.85B923.2M1.22B248.7M
Current liabilities282.8M155.3M138.7M79.9M470.3M306.6M100.8M
Total debt34.0M42.9M46.5M2.24M5.15M67.9M
Total liabilities291.2M173.2M167.7M116.1M470.3M308.9M106.0M
Shareholders' equity10.7B2.85B2.14B1.23B541.6M912.3M141.8M
Shares outstanding828.3M78.6M74.5M71.7M69.8M63.5M60.8M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-1.44B-1.02B-1.01B-361.0M-289.8M-180.6M-209.7M
Capital spending-8.18M-7.35M-1.97M-22.4M-2.12M-573.0K-2.34M
Free cash flow-1.45B-1.03B-1.01B-383.4M-292.0M-181.2M-212.0M
Cash from investing-3.55B1.87M-24.1M-1.48M204.0K99.0M
Cash from financing2.66B2.64B1.13B28.3M1.16B57.6M
Change in cash10.4B-1.77B1.62B838.4M-285.4M975.1M-50.8M

Open Financials

Cap table

Built by 6ix from Lin BioScience, Inc.’s releases

Common shares
829,200,000
Fully diluted
829,200,000

Fully diluted

LineShares
Common shares829,200,000

Share count over time

CountShares
Nov 22, 2026829,200,000

Open Cap table

Shareholders

Register

HolderSharesOf the companyAs of
英屬維京群島商Lin Scientific Inc.68.4M8.2%Oct 31, 2026
王正琪5.49M0.66%Oct 31, 2026
林雨新3.14M0.38%Oct 31, 2026
陳菀姍1.36M0.16%Oct 31, 2026
吳宗竹780K0.09%Oct 31, 2026
梁維仁00.00%Oct 31, 2026
王惠鈞00.00%Oct 31, 2026
涂三遷00.00%Oct 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Irene WangPresident & CSO · Since at least Nov 27, 2024
Serena ChenCFO · Since at least Nov 27, 2024
Tom LinChairman · Since at least Nov 27, 2024

Open People

Log in to ask 6ix AI your own questions about Lin BioScience, Inc.